Références

1.  Baudin ED, Sabourin M, Ruffi é JC et al. Les tumeurs neuro-endocrines gastro-entéropancréatiques. Médecine Thérapeutique Endocrinologie et Reproduction 1999;1:165-74.

2.  Frilling A, Akerström G, Falconi M et al. Neuro-endocrine tumor disease: an evolving landscape. Endoor Relat Cancer 2012;19(5):R163-85.

3.  Niederle MB, Hackl M, Kaserer K, Niederle B. Gastroenteropancreatic neuro-endocrine tumours: the current incidence and staging based on the WHO and European Neuro-endocrine Tumour Society classifi cation: an analysis based on prospectively collected parameters. Endocr Relat Cancer 2010;17(4):909-18.

4.  Yao JC, Hassan M, Phan A et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuro-endocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008;26(18):3063-72.

5.  Schott M, Klöppel G, Raffel A, Saleh A, Knoefel WT, Scherbaum WA. Neuro-endocrine neoplasms of the gastrointestinal tract. Dtsch Arztebl Int 2011;108(18):305-12.

6.  Modlin IM, Oberg K, Chung DC et al. Gastroenteropancreatic neuro-endocrine tumours. Lancet Oncol 2008;9(1):61-72.

7.  Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC. Risk factors associated with neuro-endocrine tumors: A U.S.-based case-control study. Int J Cancer 2008;123(4):867-73.

8.  Lepage C, Bouvier AM, Phelip JM, Hatem C, Vernet C, Faivre J. Incidence and management of malignant digestive endocrine tumours in a well defi ned French population. Gut 2004; 53(4):549-53.

9.  Thésaurus national de cancérologie digestive. Tumeurs endocrines digestives. Société nationale française de gastroentérologie, 2011.

10.  Hemminki K, Li X. Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden. Cancer 2001;92(8):2204-10.

11.  Westergaard T, Frisch M, Melbye M. Carcinoid tumors in Denmark 1978-1989 and the risk of subsequent cancers. A population-based study. Cancer 1995;76(1):106-9.

12.  Klöppel G. Classifi cation and pathology of gastroenteropancreatic neuro endocrine neoplasms. Endocr Relat Cancer 2011;18(Suppl. 1):S1-16.

13.  Tenenbaum F. Scintigraphie des récepteurs à la somatostatine. Médecine Thérapeutique Endocrinologie et Reproduction 2000;2:423-9


Copyright © 2017 Ipsen, tous droits réservés - Google+ - Mentions légales